期刊文献+

盐酸克仑特罗双层缓释片的研制及体内外评价 被引量:1

Preparation and Evaluation in vivo and in vitro of Clenbuterol Hydrochloride Sustained-release Bilayer Tablets
原文传递
导出
摘要 目的研制盐酸克仑特罗缓释双层片并考察其体外释放及犬体内药动学。方法以羟丙甲纤维素和乙基纤维素为骨架材料,分别采用粉末直接压片和湿法制粒技术制备盐酸克仑特罗双层缓释片。测定其体外释放度和Beagle犬口服单剂量盐酸克仑特罗普通片和双层缓释片后血浆中药物的浓度,推算药动学参数。结果盐酸克仑特罗双层缓释片体外释放符合Higuehi方程。盐酸克仑特罗双层缓释片和普通片的有关药动学参数如下:t1/2分别为(11.90±1.42),(6.18±0.81)h;Cmax为(5.86±0.33),(11.43±0.64)ng·mL^-1;tmax为(3.17±0.73),(2.02±0.35)h;AUC0~1.为(65.08±2.63),(68.00±2.89)ng·h·mL^-1。结论盐酸克仑特罗双层缓释片体外具有明显的速释和缓释特性。体内平均滞留时间长于普通片。体外释放和体内吸收有良好的相关性。 OBJECTIVE To prepare clenbuterol hydrochloride sustained-release bilayer tablets and study its pharmaceutical characteristics in vivo and in vitro. METHODS HPMC and EC mixed matrix were used to prepare clenbuterol bydrochloride sustained-release bilayer tablets by direct compression technique and wet granulation technique. The release characteristics in vitro and pharmacokinetics in dogs of clenbuterol hydrochloride sustained-release bilayer tablets were investigated. RESULTS The drug dissolution of sustained-release bilayer tablets was consistent with Higuchi equation. The peak levels ( Cmax ) after administration of sustained-release bilayer tablets and reference tablets were (5.86 ± 0.33 ) and (11.43 ± 0.64) ng ·mL^-1 at (3. 17± 0.73 ) and (2.02 ±0.35) h, respectively. The mean elimination half lives ( tl/2 ) were found to be ( 11.90 ±1.42) and ( 6.18 ±0.81 ) h, respectively. AUC0-1 were calculated to be (65.08 ± 2.63 ) and (68.00 ± 2.89) ng · h · mL^-1 , respectively. CONCLUSION The clenbuterol hydrochloride sustained-release bilayer tablets exhibited both sustained-and rapid-release characteristics in vitro. The calculated MRT of sustained-release bilayer tablets was significantly more than that of reference tablets. There existed correlation between the in vitro release and in vivo absorption.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第1期46-49,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 盐酸克仑特罗 双层缓释片 体内外相关性 clenbuterol Hydrochloride sustained-release bilayer tablets in vitro and in vivo correlation
  • 相关文献

参考文献9

二级参考文献29

  • 1罗霞萍,陈执中.RP-HPLC测定喘立舒中沙丁胺醇及异丙阿托品的含量[J].中国药学杂志,1994,29(3):163-164. 被引量:4
  • 2张淑秋,谢茵,郝正华,袁鸿,冷光.卡托普利缓释骨架片的研究[J].中国药学杂志,1996,31(11):668-669. 被引量:12
  • 3[1]Chidambaram N,Porter W,Flood K.Formulation and characterization of new layered diffusional matrices for zero-order sustained release[J].J Controlled Release,1998,52:149.
  • 4[2]Conte U,Maggi L,Colombo P,et al.Multi-layered hydrophilic matrices as constant release devices[J].J Controlled Release,1993,26:39.
  • 5[3]Conte U,Maggi L.Multilayer tablets as drug delivery devices[J].Pharm Tech,1998,3:174.
  • 6[4]Colombo P,Conte U,Gazzaniga A,et al.Drug release modulation by physical restrictions of matrix swelling[J].Int J Pharm,1990,63:43.
  • 7[5]Baveja SK,Rao KVR,Scingh A.Sustained release tablet formulation of diethylcarbomazine[J].Int J Pharm,1984,19:229.
  • 8[6]Kim C.Compressed donut-shaped tablets with zero-order release kinetics[J].Pharm Res,1995,12:1045.
  • 9[7]Hildgen P,McMullen JN.A new gradient matrix:formulation and characterization[J].J Controlled Release,1995,34:263.
  • 10[8]Scott DC,Hollenbeck RG.Design and manufacture of a zero-order sustained-release pellet dosage form through nonuniform drug distribution in a diffusional matrix[J].Pharm Res,1991,8:156.

共引文献55

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部